Cross Country Healthcare Q3 revenue $442M (-30% YoY), net income $12.8M (-63%), EPS $0.36 vs loss $0.57

CROSS COUNTRY HEALTHCARE INC

2023-Q3 EPS reported $1.78 revenue$1,605,693,000

Revenue of $442.3M, down 30% from Q3 2022 and 18% from Q2 2023.
Net income $12.8M, down 63% YoY and 40% sequentially.
Diluted EPS of $0.36, compared to a loss of $0.57 in Q3 2022.
Adjusted EBITDA $27.2M (6.2% margin), down 57% YoY and 380 bps margin contraction.
Operating cash flow $70.3M, down 50% from Q3 2022.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.65

CROSS COUNTRY HEALTHCARE INC reported financial results for quarter ended September 30, 2023.

Period: quarter ended September 30, 2023
Result: reported results

Exact text from the filing

On November 1, 2023 , Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended September 30, 2023 , a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

View on SEC.gov

Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0001157523-23-001599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.